Governments are moving toward approving the first vaccines to contain Covid-19, but public concerns about dosage safety are threatening to undermine those efforts. A survey by the University of Hamburg found that about 40% of respondents in seven European countries were hesitant or unwilling to prepare for the Covid-19 vaccine …
Read More »
Federal health regulators have ruled out a leading Covid-19 vaccine candidate from AstraZeneca AZN in the U.S. Allowed the study to resume. 0.08% According to a person familiar with the matter and content reviewed by Wall Street Journal, PLC and Oxford University. U.S. The Food and Drug Administration wrapped up …
Read More »
Pfizer Inc. P.F.E. -0.84% Said it may be ready to apply for emergency-use authorization of its Covid-19 vaccine by the end of November, believing that in late-stage human trials will yield positive efficacy and safety data, the first time it or any other leading Western vaccine developer This kind of …
Read More »